On the recordJune 21, 2010
Already, FDA's inconsistent approval process has dampened investment.
Source
congress.govAlready, FDA's inconsistent approval process has dampened investment.
Warner notes that FDA approval inconsistencies are harming investment in medical devices.
Share
More from Mark Warner